QUANTITATIVE APPROACH TO ASSIST NEUROBLASTOMA ASSESSMENT BY MEASURING I-123 mIBG UPTAKE IN SCINTIGRAPHIC IMAGES
Whole-body <sup>123</sup>I-Metaiodobenzylguanidine (mIBG) scintigraphy is used as the primary image modality in neuroblastoma detection. It is the most sensitive and specific method for staging and response evaluation. Validated semi-quantitative scoring methods with low interobserver va...
Main Authors: | Rafael Martínez-Díaz, Julia Balaguer, Luis Manuel Sánchez-Ruiz, Pilar Bello, Victoria Castel, Antonio Rivas, Adela Cañete, Marina Falgas, Jose Luis Loaiza, Guillermo Perís-Fajarnés |
---|---|
Format: | Article |
Language: | English |
Published: |
Slovenian Society for Stereology and Quantitative Image Analysis
2015-03-01
|
Series: | Image Analysis and Stereology |
Subjects: | |
Online Access: | http://www.ias-iss.org/ojs/IAS/article/view/1219 |
Similar Items
-
Analysis of quantitative [I-123] mIBG SPECT/CT in a phantom and in patients with neuroblastoma
by: Samuel L. Brady, et al.
Published: (2019-12-01) -
MIBG Therapy for Neuroblastoma: Precision Achieved With Dosimetry, and Concern for False Responders
by: Pedro M. Rubio, et al.
Published: (2020-05-01) -
Upfront consolidation treatment with 131I‐mIbG followed by myeloablative chemotherapy and hematopoietic stem cell transplantation in high‐risk neuroblastoma
by: Jianhua Feng, et al.
Published: (2020-09-01) -
EANM Dosimetry Committee series on standard operational procedures for internal dosimetry for 131I mIBG treatment of neuroendocrine tumours
by: Jonathan Gear, et al.
Published: (2020-03-01) -
Diagnostic Use of Post-therapy <sup>131</sup>I-Meta-Iodobenzylguanidine Scintigraphy in Consolidation Therapy for Children with High-Risk Neuroblastoma
by: Hiroshi Wakabayashi, et al.
Published: (2020-09-01)